Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROGRESSIVE-AF: First-Line Ablation vs Drugs for AF
NCT05514860Unknown
- Sponsor
- University of British Columbia
- Start
- Jan 2017
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by University of British Columbia. Primary endpoint: Time to First Occurrence of Persistent Atrial Tachyarrhythmia at 36 months. Status: unknown.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05514860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514860.